Management of postoperative Crohn's disease

American Journal of Gastroenterology

Volumn 103, Issue 4, 2008, Pages 1029-1035

  Ng, Siew C ^a   Kamm, Michael A ^a,b  

^a ST MARK S HOSPITAL   (United Kingdom)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; BIOLOGICAL FACTOR; BUDESONIDE; FISH OIL; IMIDAZOLE DERIVATIVE; IMMUNOMODULATING AGENT; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; NITROIMIDAZOLE; OMEGA 3 FATTY ACID; ORDINAZOLE; PLACEBO; PROBIOTIC AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 10; RIFAXIMIN; SALAZOSULFAPYRIDINE; STEROID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ANASTOMOSIS; COLONOSCOPY; CROHN DISEASE; DISEASE COURSE; DRUG DOSE COMPARISON; GASTROINTESTINAL ENDOSCOPY; HIGH RISK PATIENT; HUMAN; ILEITIS; ILEUM RESECTION; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE RESECTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; REOPERATION; REVIEW; RISK FACTOR; UNSPECIFIED SIDE EFFECT;

COLECTOMY; COLONOSCOPY; CROHN DISEASE; HUMANS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RECURRENCE;

EID: 41849084126     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.01795.x     Document Type: Review

References (55)

1. Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990 99 : 956 63.
2. Olaison G, Smedh K, Sjodahl R. Natural course of Crohn's disease after ileocolic resection: Endoscopically visualised ileal ulcers preceding symptoms. Gut 1992 33 : 331 5.
3. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and post-operative recurrence in Crohn's disease. Ann Surg 2000 231 : 38 45.
4. Rutgeerts P, Geboes K, Vantrappen G, et al. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 1984 25 : 665 72.
5. D'Haens GR, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal excluded ileum. Gastroenterology 1998 114 : 262 7.
6. Cameron JL, Hamilton SR, Coleman J, et al. Patterns of ileal recurrence in Crohn's disease. A prospective randomized study. Ann Surg 1992 215 : 546 52.
7. Louis E, Collard A, Oger AF, et al. Behaviour of Crohn's disease according to the Vienna classification: Changing pattern over the course of the disease. Gut 2001 49 : 777 82.
8. D'Haens GR, Gasparaitis AE, Hanauer SB. The length of recurrent ileitis after ileocolonic resection correlates with presurgical extent of Crohn's disease. Gastroenterology 1993 104 : A692.
9. Pallone F, Boivirant M, Antonietta M, et al. Analysis of clinical course of postoperative recurrence in Crohn's disease of distal ileum. Dig Dis Sci 1992 37 : 215 9.
10. Chardavoyne R, Flint GW, Pollack S, et al. Factors affecting recurrence following resection for Crohn's disease. Dis Colon Rectum 1986 29 : 495 502.
11. Hanauer SB, Korelitz BI, Rutgeerts P, et al. Post-operative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamie, or placebo: A 2-year trial. Gastroenterology 2004 127 : 723 9.
12. Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: A prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 1989 30 : 983 9.
13. Daperno M, D'Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: The SES-CD. Gastrointest Endosc 2004 60 : 505 12.
14. Bourreille A, Jarry M, Halluin PN, et al. Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn's disease: A prospective study. Gut 2006 55 : 978 83.
15. Rispo A, Bucci L, Pesce G, et al. Bowel sonography for the diagnosis and grading of postsurgical recurrence of Crohn's disease. Inflamm Bowel Dis 2006 12 : 486 90.
16. Yamamoto T, Keighley MR. Smoking and disease recurrence after operation for Crohn's disease. Br J Surg 2000 87 : 398 404.
17. Cottone M, Orlando A, Viscido A. Review article: prevention of postsurgical relapse and recurrence in Crohn's disease. Aliment Pharmacol Ther 2003 17 (Suppl 2 38 42.
18. Cottone M, Rosselli M, Orlando A, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994 106 : 643 8.
19. Travis S, Stange EF, Lemann M, et al. European evidence-based consensus on the diagnosis and management of Crohn's disease: Current management. Gut 2006 55 : i16-35.
20. Sutherland LR, Ramcharan S, Bryant H, et al. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990 98 : 1123 8.
21. Cosnes J, Carbonnel F, Beaugerie L, et al. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 1996 110 : 424 31.
22. Rutgeerts P. Strategies in the prevention of post-operative recurrence in Crohn's disease. Best Pract Res Clin Gastroenterol 2003 17 : 63 73.
23. Bernell O, Lapidus A, Hellers G. Recurrence after colectomy in Crohn's colitis. Dis Colon Rectum 2001 44 : 647 54.
24. de Dombal FT, Burton I, Goligher C. The early and late results of surgical treatment for Crohn's disease. Br J Surg 1971 11 : 805 16.
25. Greenstein AJ, Lachman P, Sachar DB, et al. Perforating and non-perforating indications for repeated operations in Crohn's disease: Evidence for two clinical forms. Gut 1988 29 : 588 92.
26. Summers RW, Switz DM, Sessions JT Jr., et al. National Cooperative Crohn's Disease Study: Results of drug treatment. Gastroenterology 1979 77 : 847 69.
27. Wenckert A, Kristensen M, Eklund AE, et al. The long-term prophylactic effect of salazosulphapyridine (Salazopyrin) in primarily resected patients with Crohn's disease. A controlled double blind trial. Scand J Gastroenterol 1978 13 : 161 7.
28. Ewe K, Herfarth C, Malchow H, et al. Postoperative recurrence of Crohn's disease in relation to radicality of operation and sulfasalazine prophylaxis: A multicenter trial. Digestion 1989 42 : 224 32.
29. Lochs H, Mayer M, Fleig WE, et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterology 2000 118 : 264 73.
30. Mcleod RS, Wolff BG, Steinhart AH, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 1995 109 : 404 13.
31. Caprilli R, Cottone M, Tonelli F, et al. Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: A pragmatic, double-blind, randomized controlled trial. Aliment Pharmacol Ther 2003 17 : 517 23.
32. Camma C, Giunta M, Rosselli M, et al. Mesalamine in the maintenance treatment of Crohn's disease: A meta-analysis adjusted for confounding variables. Gastroenterology 1997 113 : 1465 73.
33. Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995 108 : 1617 21.
34. Rutgeerts P, Van Assache G, Vermeire S, et al. Ordinazole for prophylaxis of post-operative Crohn's disease recurrence: A randomized, double blind, placebo-controlled trial. Gastroenterology 2005 128 : 856 61.
35. Ardizzone S, Maconi G, Sampietro GM, et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 2004 127 : 730 40.
36. Markowitz J, Grancher K, Kohn N, et al. A multi-center trial of 6-mercaptopurine and prednisolone in children with newly diagnosed Crohn's disease. Gastroenterology 2000 119 : 895 902.
37. Present DH, Korelitz BL, Wisch N, et al. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double blind study. N Engl J Med 1980 302 : 981 7.
38. D'Haens G, Noman M, Van Assche G, et al. Severe post-operative recurrence of Crohn's disease is significantly reduced with combination therapy metronidazole and azathioprine: A double-blind controlled randomized trial. Gastroenterology 2007 132 : 289.
39. Papay P, Ho E, Reinisch W, et al. Azathioprine (6-mercaptopurine reduces the risk of intestinal re-operation in Crohn's disease. Gastroenterology 2007 132 : 289.
40. Rutgeerts P, Feagan BG, Lichtenstein GR, et al. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology 2004 126 : 402 13.
41. Lichtenstein GR, Yan S, Bala M, et al. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology 2005 128 : 862 9.
42. Hommes D, Baert F, Van Assche G, et al. A randomized controlled trial evaluating the ideal medical management for Crohn's disease: Top-down vs step-up strategies. Gastroenterology 2005 128 : A577.
43. Sorrentino D, Terrosu G, Avellini C, et al. Prevention of postoperative recurrence of Crohn's disease by infliximab. Eur J Gastroenterol Hepatol 2006 18 : 457 9.
44. Biancone L, Cretella M, Tosti C, et al. Local injection of infliximab in the postoperative recurrence of Crohn's disease. Gastrointest Endosc 2006 63 : 486 92.
45. Belluzzi A, Campieri M, Belloli C, et al. A new enteric-coated preparation of omega 3 fatty acids for preventing post-surgical recurrence in Crohn's disease. Gastroenterology 1997 112 : A930.
46. Calderwood S, Kilpatrick L, Douglas SD, et al. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b. Blood 2001 97 : 376 82.
47. Dejaco C, Lichtenberger C, Miehslen W, et al. An open-label pilot study of granulocyte colony-stimulating factor for the treatment of severe endoscopic postoperative recurrence in Crohn's disease. Digestion 2003 68 63 70.
48. Ewe K, Bottger T, Buhr HJ, et al. Low-dose budesonide treatment for prevention of post-operative recurrence of Crohn's disease: A multi-centre randomized placebo-controlled trial. German Budesonide Study Group. Eur J Gastroenterol Hepatol 1999 11 : 277 82.
49. Hellers G, Cortot A, Jewells D, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology 1999 116 : 294 300.
50. Campieri M, Rizzello F, Venturi A, et al. Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of postoperative recurrence of Crohn's disease: A randomized study vs mesalamine. Gastroenterology 2000 118 : 4179.
51. Prantera C, Scribano ML, Falasco G, et al. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: A randomized controlled trial with Lactobacillus GG. Gut 2002 51 : 405 9.
52. Marteau P, Lemann M, Seksik P, et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: A randomized, double-blind, placebo-controlled GETAID trial. Gut 2006 55 : 842 7.
53. Chermesh I, Tamir A, Reshef R, et al. Failure of Synbiotic 2000 to prevent post-operative recurrence of Crohn's disease. Dig Dis Sci 2007 52 : 385 9.
54. Marteau P, Lemann M, Seksik P, et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: A randomized, double-blind, placebo-controlled GETAID trial. Gut 2006 55 : 842 7.
55. Colombel JF, Rutgeerts P, Malchow H, et al. Interleukin 10 (Tenovil) in the prevention of post-operative recurrence of Crohn's disease. Gut 2001 49 : 42 6.